North Star Investment Management’s Boston Scientific BSX Stock Holding History

North Star Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$163K	Buy	2,597 +7	+0.3%	+$560	0.01%	523
2025 Q4	$247K	Buy	2,590 +27	+1%	+$2.65K	0.02%	420
2025 Q3	$250K	Hold	2,563	–	–	0.02%	403
2025 Q2	$275K	Hold	2,563	–	–	0.02%	377
2025 Q1	$259K	Hold	2,563	–	–	0.02%	380
2024 Q4	$229K	Hold	2,563	–	–	0.02%	397
2024 Q3	$215K	Hold	2,563	–	–	0.01%	410
2024 Q2	$197K	Sell	2,563 -57	-2%	-$4.17K	0.01%	410
2024 Q1	$179K	Buy	2,620 +57	+2%	+$3.67K	0.01%	437
2023 Q4	$148K	Hold	2,563	–	–	0.01%	451
2023 Q3	$135K	Hold	2,563	–	–	0.01%	462
2023 Q2	$139K	Hold	2,563	–	–	0.01%	474
2023 Q1	$128K	Hold	2,563	–	–	0.01%	484
2022 Q4	$119K	Buy	2,563 +47	+2%	+$2.04K	0.01%	475
2022 Q3	$97K	Hold	2,516	–	–	0.01%	452
2022 Q2	$94K	Hold	2,516	–	–	0.01%	455
2022 Q1	$111K	Buy	2,516 +236	+10%	+$10.2K	0.01%	452
2021 Q4	$97K	Hold	2,280	–	–	0.01%	488
2021 Q3	$99K	Hold	2,280	–	–	0.01%	476
2021 Q2	$97K	Hold	2,280	–	–	0.01%	484
2021 Q1	$88K	Hold	2,280	–	–	0.01%	465
2020 Q4	$82K	Hold	2,280	–	–	0.01%	461
2020 Q3	$87K	Hold	2,280	–	–	0.01%	428
2020 Q2	$80K	Hold	2,280	–	–	0.01%	422
2020 Q1	$74K	Buy	2,280 +100	+5%	+$3.91K	0.01%	425
2019 Q4	$99K	Hold	2,180	–	–	0.01%	435
2019 Q3	$89K	Buy	+2,180	New	+$92.4K	0.01%	442
2019 Q2	–	Sell	-2,280	Closed	-$88K	–	454
2019 Q1	$88K	Hold	2,280	–	–	0.01%	461
2018 Q4	$81K	Buy	2,280 +1,200	+111%	+$43.5K	0.01%	447
2018 Q3	$42K	Hold	1,080	–	–	﹤0.01%	595
2018 Q2	$35K	Hold	1,080	–	–	﹤0.01%	628
2018 Q1	$30K	Hold	1,080	–	–	﹤0.01%	656
2017 Q4	$27K	Hold	1,080	–	–	﹤0.01%	663
2017 Q3	$32K	Hold	1,080	–	–	﹤0.01%	621
2017 Q2	$30K	Hold	1,080	–	–	﹤0.01%	618
2017 Q1	$27K	Buy	1,080 +600	+125%	+$14.6K	﹤0.01%	622
2016 Q4	$10K	Hold	480	–	–	﹤0.01%	743
2016 Q3	$11K	Hold	480	–	–	﹤0.01%	622
2016 Q2	$11K	Hold	480	–	–	﹤0.01%	617
2016 Q1	$9K	Hold	480	–	–	﹤0.01%	598
2015 Q4	$9K	Hold	480	–	–	﹤0.01%	593
2015 Q3	$8K	Hold	480	–	–	﹤0.01%	644
2015 Q2	$8K	Hold	480	–	–	﹤0.01%	645
2015 Q1	$9K	Hold	480	–	–	﹤0.01%	628
2014 Q4	$6K	Hold	480	–	–	﹤0.01%	679
2014 Q3	$6K	Hold	480	–	–	﹤0.01%	559
2014 Q2	$6K	Hold	480	–	–	﹤0.01%	603
2014 Q1	$6K	Buy	+480	New	+$6.3K	﹤0.01%	577

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

North Star Investment Management's BSX Position: Q1 2026 in Review

North Star Investment Management increased its Boston Scientific (BSX) stake by 0.27% in Q1 2026, buying an estimated $560 and bringing the position to 2,597 shares worth $163K. The position accounts for 0.01% of the portfolio, ranked #523.

North Star Investment Management first reported a position in BSX in Q1 2014 and has held it in 48 quarters since. The position peaked at $275K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

North Star Investment Management held 2,597 shares of Boston Scientific worth $163K as of Q1 2026.
North Star Investment Management bought 7 Boston Scientific shares in Q1 2026, an estimated $560.
Boston Scientific made up 0.01% of North Star Investment Management's portfolio in Q1 2026, its #523 holding.
North Star Investment Management first reported a position in Boston Scientific in Q1 2014 and has held it in 48 quarters since.
North Star Investment Management's Boston Scientific position peaked at $275K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.